NPFF

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, NPFF RNA is linked to patient survival in 1 of 34 cancer types, making it a survival-associated NPFF data layer compared with 3 for mutation status.

The strongest signal is observed in small cell lung cancer (SCLC), where higher NPFF RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated NPFF expression acts as an unfavorable survival marker, although some lineages such as SCLC show a favorable association.

SCLC are the cancer types where NPFF RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
SCLCDFSMedianIII,IV0.5080.245.0256view →
Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

NPFF–SCLC (DFS)

Kaplan–Meier survival curve for NPFF RNA-high vs -low samples in SCLC.

Open the SCLC breakdown →

Exploration